Cryo Cell International (CCEL) Long-Term Deferred Tax (2010 - 2026)

Cryo Cell International (CCEL) has 15 years of Long-Term Deferred Tax data on file, last reported at $23.6 million in Q1 2026.

• Quarterly Long-Term Deferred Tax rose 13.55% year-over-year to $23.6 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $23.6 million (up 13.55% YoY) and the FY2025 annual result came in at $23.6 million, up 13.55% from the prior year.
• Long-Term Deferred Tax was little changed at $23.6 million in Q1 2026 per CCEL's latest filing, from $23.6 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $23.6 million in Q4 2025 and bottomed at $12.0 million in Q1 2022.
• The 5-year median for Long-Term Deferred Tax is $20.5 million (2023), against an average of $17.8 million.
• The widest annual swing landed in 2023, when Long-Term Deferred Tax surged 49.12%; it then climbed 1.51% in 2024.
• Tracing CCEL's Long-Term Deferred Tax over 5 years: stood at $13.7 million in 2022, then soared by 49.12% to $20.5 million in 2023, then advanced by 1.51% to $20.8 million in 2024, then advanced by 13.55% to $23.6 million in 2025, then changed by 0.0% to $23.6 million in 2026.
• Per Business Quant, the three latest CCEL Long-Term Deferred Tax figures stand at $23.6 million (Q1 2026), $23.6 million (Q4 2025), and $20.8 million (Q3 2025).

Peer Comparison